Comparable EPS grew 12% year-over-year to $3.73, with strong ROE at 17% and robust free cash flow. Segment results were mixed, but strategic initiatives and capital allocation support a raised 2026 EPS outlook of $14.40–$14.80. Risks include macroeconomic and market uncertainties.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.